Erasca is a clinical-stage precision oncology company dedicated to discovering, developing, and commercializing innovative medicines for cancer patients. By targeting the RAS/MAPK signaling pathway, which is implicated in numerous cancers affecting millions globally, Erasca aims to create therapies that can make a significant impact on patient outcomes. The company's name reflects its mission: an audacious hope to “erase cancer.” Erasca fosters a collaborative and inclusive environment, emphasizing core values such as patient commitment, scientific integrity, and teamwork. Through its relentless focus on advanced treatment options, Erasca is committed to improving the lives of those affected by cancer, while providing essential growth opportunities for its employees across various functions within the organization.